Ms Jennifer Levy > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices

1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Ms Jennifer Levy

Position
Jenny Levy is a litigation partner who has been with Kirkland for 23 years. She has appeared before trial courts and arbitration panels across the country. Jenny focuses on complex commercial litigation, state Attorney General litigation and investigations, pharmaceutical litigation, and product liability cases. She has litigated a wide variety of cases including consumer protection actions, public nuisance claims, allegations of fraud and misrepresentation, data breaches, breach of contract, business torts, product liability, antitrust, false claims qui tam actions, and class actions. Her practice has involved a diverse array of subject matters and allegations including Public Nuisance, Medicaid/Medicare fraud, drug pricing fraud and unfair competition (AWP/WAC inflation), HIPAA, HITECH violations, contracts for the sale of energy, state and federal Fair Debt Collection Act violations, collection contracts for the sale of businesses and stock purchase agreements, alleged violations of shareholder agreements, international licensing agreements, allegations of unlawful insurance practices, conspiracy and antitrust violations, and numerous product liability cases on behalf of manufacturers of automotive products, lead products, tobacco and pharmaceuticals. Jenny is a pro bono coordinator for Kirkland’s Washington, D.C. office.
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Combining first-chair trial skills, alongside deep subject knowledge and procedural expertise, Kirkland & Ellis LLP is a popular choice among many leading life sciences companies to defend them against high-stakes product liability disputes throughout the country. Many of these take the form of MDLs/class actions, with the firm excelling in taking on leadership roles as national co-ordinating counsel, as well as handling key hearings – where it shines at explaining complex scientific issues to juries. The firm’s longstanding relationship with Abbott Laboratories recently saw it representing the Chicago-based medical device company in an MDL stemming from allegations regarding its recalled baby formula sickened infants. The firm has also had a key role in the sprawling opiate litigation on behalf of Allergan and continues to defend it against ongoing claims by hundreds of private and public entities that opted out of the recent global settlement. Washington DC-based Mike Brock is ‘a superb trial lawyer across product lines’ and remains particularly active in the life sciences space. Brock is a key member of the team along with Washington DC-based Jennifer Levy  and Donna Welch in Chicago, with all three having a key role in the aforementioned Allergan matter.
United States > Government > State attorneys general
Kirkland & Ellis LLPÂ is well-equipped to support a broad range of companies in matters involving state attorneys general, investigations, and enforcement actions. Split between Chicago and Washington DC, the team routinely engages with some of the largest multistate investigations, covering issues including consumer protection, antitrust, data privacy, and ESG. Chicago-based former Illinois attorney general Lisa Madigan is a breakout star with diverse expertise in the fields of consumer protection, data privacy, healthcare, and the environment, while Donna Welch has secured key wins in litigation against pharmaceutical companies. In DC, Reginald Brown provides strategic counsel and crisis management assistance to clients facing complex and significant regulatory, enforcement and reputational matters, and Jennifer Levy is an excellent choice for state AG litigation, particularly with regard to pharmaceuticals and product liability. Brian Benczkowski has significant investigations and enforcement experience, and counts among his strengths healthcare, tech and financial services. Raya Treiser is a key contact for ESG matters, with strong relationships in the energy sector. Mark Filip, who splits his time between both offices, leads on defenses and investigations concerning pharmaceutical, healthcare, and tech companies, while Olivia Adendorff, who also has a base in Dallas, supports on consumer protection, false advertising, antitrust, and ESG claims.
Lawyer Rankings
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- State attorneys general United States > Government
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism